German Boehringer Ingelheim and US-based biotech firm Autigen are partnering up to discover and develop potential hearing loss treatments, the company has announced in a press release on Wednesday, as reported by industry media Fierce Biotech.
Under the terms, Boehringer makes an undisclosed upfront payment to Autigen, funding the firm’s research into a drug that will restore sensory hair cells. When these are damaged, it can lead to the inner-ear condition known as sensorineural hearing loss (SNHL).
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Ambu board had started headhunting process long before firing of CEO
Thursday’s CEO change had been in the works for a while, says Ambu’s board chair Jørgen Jensen.
Nine new drugs recommended for approval by CHMP at May meeting
During this month’s meeting of the CHMP, the EMA’s expert committee, a total of nine new drugs have been recommended while six drugs have had indication extensions accepted. Two treatments have been rejected.
Britt Meelby Jensen wants to rebuild trust in Ambu
After a turbulent time for Ambu under Juan Jose Gonzalez’s reign, new chief executive appointee Britt Meelby Jensen aims to rebuild the trust in the medtech firm, which has downgraded its expectations seven times over the past three years.
Outgoing Ambu CEO commends colleagues
”A true privilege,” says Juan Jose Gonzalez, describing his time as CEO at Ambu, which came to an end with Thursday’s announcement that Britt Meelby Jensen would take over the role.
Top news from MedWatch this week
Miss anything?
Laboratory technician for process development and clinical manufacturing 
Client Talent Acquisition Specialist 
Director for innovative pre-clinical testing unit 
Clinical Trial Manager 
Communications Consultant 
Consultant Manager 
Senior Manager, Clinical Trial Budget 
Account Manager 
Biostatistician 
Director Global Engineering 
System Sales Development Consultant - Investment Projects, Merck Millipore 
KLIFO is looking for a Clinical Supply Manager for our Glostrup office 
Biomarker Operations Lead 
CMO Operations Specialist - screening & selection of CMO/CDMO’s 
Key Account Manager, Europe and Asia